Notch2-induced COX-2 expression enhancing gastric cancer progression

Yun Chien Tseng, Yu Hui Tsai, Min Jen Tseng, Kai Wen Hsu, Min Chieh Yang, Kuo Hung Huang, Anna Fen Yau Li, Chin Wen Chi, Rong Hong Hsieh, Hung Hai Ku, Tian-Shun Tsai

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Gastric carcinoma is one of the most common and mortal types of malignancy worldwide. To date, the mechanisms controlling its aggressiveness are not yet fully understood. Notch signal pathway can function as either an oncogene or a tumor suppressor in tumorigenesis. Four members (Notch1-4) of Notch receptors were found in mammals and each exhibits distinct roles in tumor progression. Previous study showed that the activated Notch1 receptor promoted gastric cancer progression through cyclooxygenase-2 (COX-2). This study addressed whether Notch2 signal pathway is also involved in gastric cancer progression. Constitutive expression of Notch2 intracellular domain (N2IC), the activated form of Notch2 receptor, promoted both cell proliferation and xenografted tumor growth of human stomach adenocarcinoma SC-M1 cells. The colony formation, migration, invasion, and wound-healing abilities of SC-M1 cells were enhanced by N2IC expression, whereas these abilities were suppressed by Notch2 knockdown. Similarly, Notch2 knockdown inhibited cancer progressions of AGS and AZ521 gastric cancer cells. Expression of N2IC also caused epithelial-mesenchymal transition in SC-M1 cells. Furthermore, N2IC bound to COX-2 promoter and induced COX-2 expression through a CBF1-dependent manner in SC-M1 cells. The ability of N2IC to enhance tumor progression in SC-M1 cells was suppressed by knockdown of COX-2 or treatment with NS-398, a COX-2 inhibitor. Moreover, the suppression of tumor progression by Notch2 knockdown in SC-M1 cells was reversed by exogenous COX-2 or its major enzymatic product PGE2. Taken together, this study is the first to demonstrate that the Notch2-COX-2 signaling axis plays an important role in controlling gastric cancer progression.

Original languageEnglish
Pages (from-to)939-951
Number of pages13
JournalMolecular Carcinogenesis
Volume51
Issue number12
DOIs
Publication statusPublished - Dec 2012

Fingerprint

Cyclooxygenase 2
Stomach Neoplasms
Neoplasms
Notch2 Receptor
Signal Transduction
Stomach
Notch1 Receptor
Notch Receptors
Epithelial-Mesenchymal Transition
Cyclooxygenase 2 Inhibitors
Oncogenes
Dinoprostone
Wound Healing
Mammals
Carcinogenesis
Adenocarcinoma
Cell Proliferation
Carcinoma
Growth

Keywords

  • COX-2
  • Gastric cancer
  • Notch2 receptor
  • Tumorigenesis

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Biology

Cite this

Tseng, Y. C., Tsai, Y. H., Tseng, M. J., Hsu, K. W., Yang, M. C., Huang, K. H., ... Tsai, T-S. (2012). Notch2-induced COX-2 expression enhancing gastric cancer progression. Molecular Carcinogenesis, 51(12), 939-951. https://doi.org/10.1002/mc.20865

Notch2-induced COX-2 expression enhancing gastric cancer progression. / Tseng, Yun Chien; Tsai, Yu Hui; Tseng, Min Jen; Hsu, Kai Wen; Yang, Min Chieh; Huang, Kuo Hung; Li, Anna Fen Yau; Chi, Chin Wen; Hsieh, Rong Hong; Ku, Hung Hai; Tsai, Tian-Shun.

In: Molecular Carcinogenesis, Vol. 51, No. 12, 12.2012, p. 939-951.

Research output: Contribution to journalArticle

Tseng, YC, Tsai, YH, Tseng, MJ, Hsu, KW, Yang, MC, Huang, KH, Li, AFY, Chi, CW, Hsieh, RH, Ku, HH & Tsai, T-S 2012, 'Notch2-induced COX-2 expression enhancing gastric cancer progression', Molecular Carcinogenesis, vol. 51, no. 12, pp. 939-951. https://doi.org/10.1002/mc.20865
Tseng YC, Tsai YH, Tseng MJ, Hsu KW, Yang MC, Huang KH et al. Notch2-induced COX-2 expression enhancing gastric cancer progression. Molecular Carcinogenesis. 2012 Dec;51(12):939-951. https://doi.org/10.1002/mc.20865
Tseng, Yun Chien ; Tsai, Yu Hui ; Tseng, Min Jen ; Hsu, Kai Wen ; Yang, Min Chieh ; Huang, Kuo Hung ; Li, Anna Fen Yau ; Chi, Chin Wen ; Hsieh, Rong Hong ; Ku, Hung Hai ; Tsai, Tian-Shun. / Notch2-induced COX-2 expression enhancing gastric cancer progression. In: Molecular Carcinogenesis. 2012 ; Vol. 51, No. 12. pp. 939-951.
@article{99da2108593f4081b9ea0ae74e51ee6e,
title = "Notch2-induced COX-2 expression enhancing gastric cancer progression",
abstract = "Gastric carcinoma is one of the most common and mortal types of malignancy worldwide. To date, the mechanisms controlling its aggressiveness are not yet fully understood. Notch signal pathway can function as either an oncogene or a tumor suppressor in tumorigenesis. Four members (Notch1-4) of Notch receptors were found in mammals and each exhibits distinct roles in tumor progression. Previous study showed that the activated Notch1 receptor promoted gastric cancer progression through cyclooxygenase-2 (COX-2). This study addressed whether Notch2 signal pathway is also involved in gastric cancer progression. Constitutive expression of Notch2 intracellular domain (N2IC), the activated form of Notch2 receptor, promoted both cell proliferation and xenografted tumor growth of human stomach adenocarcinoma SC-M1 cells. The colony formation, migration, invasion, and wound-healing abilities of SC-M1 cells were enhanced by N2IC expression, whereas these abilities were suppressed by Notch2 knockdown. Similarly, Notch2 knockdown inhibited cancer progressions of AGS and AZ521 gastric cancer cells. Expression of N2IC also caused epithelial-mesenchymal transition in SC-M1 cells. Furthermore, N2IC bound to COX-2 promoter and induced COX-2 expression through a CBF1-dependent manner in SC-M1 cells. The ability of N2IC to enhance tumor progression in SC-M1 cells was suppressed by knockdown of COX-2 or treatment with NS-398, a COX-2 inhibitor. Moreover, the suppression of tumor progression by Notch2 knockdown in SC-M1 cells was reversed by exogenous COX-2 or its major enzymatic product PGE2. Taken together, this study is the first to demonstrate that the Notch2-COX-2 signaling axis plays an important role in controlling gastric cancer progression.",
keywords = "COX-2, Gastric cancer, Notch2 receptor, Tumorigenesis",
author = "Tseng, {Yun Chien} and Tsai, {Yu Hui} and Tseng, {Min Jen} and Hsu, {Kai Wen} and Yang, {Min Chieh} and Huang, {Kuo Hung} and Li, {Anna Fen Yau} and Chi, {Chin Wen} and Hsieh, {Rong Hong} and Ku, {Hung Hai} and Tian-Shun Tsai",
year = "2012",
month = "12",
doi = "10.1002/mc.20865",
language = "English",
volume = "51",
pages = "939--951",
journal = "Molecular Carcinogenesis",
issn = "0899-1987",
publisher = "Wiley-Liss Inc.",
number = "12",

}

TY - JOUR

T1 - Notch2-induced COX-2 expression enhancing gastric cancer progression

AU - Tseng, Yun Chien

AU - Tsai, Yu Hui

AU - Tseng, Min Jen

AU - Hsu, Kai Wen

AU - Yang, Min Chieh

AU - Huang, Kuo Hung

AU - Li, Anna Fen Yau

AU - Chi, Chin Wen

AU - Hsieh, Rong Hong

AU - Ku, Hung Hai

AU - Tsai, Tian-Shun

PY - 2012/12

Y1 - 2012/12

N2 - Gastric carcinoma is one of the most common and mortal types of malignancy worldwide. To date, the mechanisms controlling its aggressiveness are not yet fully understood. Notch signal pathway can function as either an oncogene or a tumor suppressor in tumorigenesis. Four members (Notch1-4) of Notch receptors were found in mammals and each exhibits distinct roles in tumor progression. Previous study showed that the activated Notch1 receptor promoted gastric cancer progression through cyclooxygenase-2 (COX-2). This study addressed whether Notch2 signal pathway is also involved in gastric cancer progression. Constitutive expression of Notch2 intracellular domain (N2IC), the activated form of Notch2 receptor, promoted both cell proliferation and xenografted tumor growth of human stomach adenocarcinoma SC-M1 cells. The colony formation, migration, invasion, and wound-healing abilities of SC-M1 cells were enhanced by N2IC expression, whereas these abilities were suppressed by Notch2 knockdown. Similarly, Notch2 knockdown inhibited cancer progressions of AGS and AZ521 gastric cancer cells. Expression of N2IC also caused epithelial-mesenchymal transition in SC-M1 cells. Furthermore, N2IC bound to COX-2 promoter and induced COX-2 expression through a CBF1-dependent manner in SC-M1 cells. The ability of N2IC to enhance tumor progression in SC-M1 cells was suppressed by knockdown of COX-2 or treatment with NS-398, a COX-2 inhibitor. Moreover, the suppression of tumor progression by Notch2 knockdown in SC-M1 cells was reversed by exogenous COX-2 or its major enzymatic product PGE2. Taken together, this study is the first to demonstrate that the Notch2-COX-2 signaling axis plays an important role in controlling gastric cancer progression.

AB - Gastric carcinoma is one of the most common and mortal types of malignancy worldwide. To date, the mechanisms controlling its aggressiveness are not yet fully understood. Notch signal pathway can function as either an oncogene or a tumor suppressor in tumorigenesis. Four members (Notch1-4) of Notch receptors were found in mammals and each exhibits distinct roles in tumor progression. Previous study showed that the activated Notch1 receptor promoted gastric cancer progression through cyclooxygenase-2 (COX-2). This study addressed whether Notch2 signal pathway is also involved in gastric cancer progression. Constitutive expression of Notch2 intracellular domain (N2IC), the activated form of Notch2 receptor, promoted both cell proliferation and xenografted tumor growth of human stomach adenocarcinoma SC-M1 cells. The colony formation, migration, invasion, and wound-healing abilities of SC-M1 cells were enhanced by N2IC expression, whereas these abilities were suppressed by Notch2 knockdown. Similarly, Notch2 knockdown inhibited cancer progressions of AGS and AZ521 gastric cancer cells. Expression of N2IC also caused epithelial-mesenchymal transition in SC-M1 cells. Furthermore, N2IC bound to COX-2 promoter and induced COX-2 expression through a CBF1-dependent manner in SC-M1 cells. The ability of N2IC to enhance tumor progression in SC-M1 cells was suppressed by knockdown of COX-2 or treatment with NS-398, a COX-2 inhibitor. Moreover, the suppression of tumor progression by Notch2 knockdown in SC-M1 cells was reversed by exogenous COX-2 or its major enzymatic product PGE2. Taken together, this study is the first to demonstrate that the Notch2-COX-2 signaling axis plays an important role in controlling gastric cancer progression.

KW - COX-2

KW - Gastric cancer

KW - Notch2 receptor

KW - Tumorigenesis

UR - http://www.scopus.com/inward/record.url?scp=84867745527&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867745527&partnerID=8YFLogxK

U2 - 10.1002/mc.20865

DO - 10.1002/mc.20865

M3 - Article

C2 - 21976141

AN - SCOPUS:84867745527

VL - 51

SP - 939

EP - 951

JO - Molecular Carcinogenesis

JF - Molecular Carcinogenesis

SN - 0899-1987

IS - 12

ER -